Viking Therapeutics announces its fourth-quarter financial results after Wednesday's closing bell. Here's a look at the ...

That suggests that "further weight loss might be achieved" by keeping patients on the treatment longer, Viking CEO Brian Lian said during a call with investors on Tuesday. Viking's drug data shows ...

Lian noted that Viking plans to move forward on the clinical path with the Food and Drug Administration (FDA) later this year for an injectable version of VK2735 and that they expect to initiate a ...

Stephanie Diaz; Investor Relations Manager; Viking Therapeutics Inc. Brian Lian; President, Chief Executive Officer, Director; Viking Therapeutics Inc. Greg Zante; C ...

Rancho Santa Fe residents and R. Roger Rowe parents Silvina and Brian Lian piloted the sleigh. The Frostys do the “snowman twirl” during the Encinitas Holiday Parade. (Silvina Lian ...

The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA. Read More on VKTX: Viking Therapeutics NewsMORE Related Stocks Indices ...

Viking held cash, cash equivalents and short-term investments of $903M, compared to $362M as of December 31, 2023. 2024 ...

The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA. Feb 02, 2022 8:56pm ET SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ...

CEO Brian Lian highlighted 2024 as an exceptionally busy year, with successful results from four studies, including the Phase 2 VENTURE trial for subcutaneous VK2735, which demonstrated up to 14.7% ...

Hello, and thank you all for participating in today's call. Joining me today is Brian Lian, Viking's President and CEO; and Greg Zante, Viking's CFO. Before we begin, I'd like to caution that ...